The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Abstract
Digoxin is one of the oldest compounds used in cardiovascular medicine. Nevertheless, its mechanism of action and most importantly its clinical utility have been the subject of an endless dispute. Positive inotropic and neurohormonal modulation properties are attributed to digoxin, and it was the mainstay of heart failure therapeutics for decades. However, since the institution of β-blockers and aldosterone antagonists as part of modern heart failure medical therapy, digoxin prescription rates have been in free fall. The fact that digoxin is still listed as a valid therapeutic option in both American and European heart failure guidelines has not altered clinicians' attitude towards the drug. Since the publication of original Digitalis Investigation Group trial data, a series of reports based predominately on observational studies and post hoc analyses have raised concerns about the clinical efficacy and long-term safety of digoxin. In the present review, we will attempt a critical appraisal of the available clinical evidence regarding the efficacy and safety of digoxin in heart failure patients with a reduced ejection fraction. The methodological issues, strengths, and limitations of individual studies will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Young, J. B., Abraham, W. T., & Smith, A. L. (2003) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.08.087 · Cited by 1,682
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Committee Members, Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,442
Normand, S.-L. T., Landrum, M. B., Guadagnoli, E., Ayanian, J. Z., Ryan, T. J., Cleary, P. D., & McNeil, B. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00321-8 · Cited by 1,235
Heart failure with preserved left ventricular systolic function
Hogg, K., Swedberg, K., & McMurray, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.046 · Cited by 932
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Van Voorhees, L., Gourley, L. A., & Jolly, M. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 827
Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
Rathore, S. S., Curtis, J. P., Wang, Y., Bristow, M. R., & Krumholz, H. M. (2003) · JAMA · doi:10.1001/jama.289.7.871 · Cited by 772
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
Rathore, S. S., Wang, Y., & Krumholz, H. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021266 · Cited by 690
(1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639
Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation · doi:10.1161/circulationaha.106.628347 · Cited by 605
Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay
Smith, T. W., Butler, V. P., & Haber, E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911272812203 · Cited by 583
Uretsky, B. F., Young, J. B., Shahidi, F. E., Yellen, L. G., Harrison, M. C., & Jolly, M. K. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90403-n · Cited by 582
Heart Failure in Outpatients: A Randomized Trial of Digoxin versus Placebo
Lee, D. C.-S., Johnson, R. A., Bingham, J. B., Leahy, M., Dinsmore, R. E., Goroll, A. H., Newell, J. B., Strauss, H. W., & Haber, E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203253061202 · Cited by 448
Ahmed, A., Rich, M. W., Love, T. E., Lloyd-Jones, D. M., Aban, I. B., Colucci, W. S., Adams, K. F., & Gheorghiade, M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi687 · Cited by 407
Ferguson, D. W., Berg, W. J., Sanders, J. S., Roach, P. J., Kempf, J. S., & Kienzle, M. G. (1989) · Circulation · doi:10.1161/01.cir.80.1.65 · Cited by 382
Principles for modeling propensity scores in medical research: a systematic literature review
Weitzen, S., Lapane, K. L., Toledano, A. Y., Hume, A. L., & Mor, V. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.969 · Cited by 344
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., Steeds, R. P., Townend, J., & Kotecha, D. (2015) · BMJ · doi:10.1136/bmj.h4451 · Cited by 341
Domanski, M., Norman, J., Pitt, B., Haigney, M., Hanlon, S., & Peyster, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00765-4 · Cited by 337
Aronow, H. D., Topol, E. J., Roe, M. T., Houghtaling, P. L., Wolski, K. E., Lincoff, A. M., Harrington, R. A., Califf, R. M., Ohman, E. M., Kleiman, N. S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04257-4 · Cited by 313
Digoxin-associated mortality: a systematic review and meta-analysis of the literature
Vamos, M., Erath, J. W., & Hohnloser, S. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv143 · Cited by 298
On principles for modeling propensity scores in medical research
Rubin, D. B. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.968 · Cited by 287
Adams, K. F., Patterson, J. H., Gattis, W. A., O’Connor, C. M., Lee, C. R., Schwartz, T. A., & Gheorghiade, M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.091 · Cited by 283
Fonarow, G. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.13.1469 · Cited by 271
Digoxin in the Management of Cardiovascular Disorders
Gheorghiade, M., Adams, K. F., & Colucci, W. S. (2004) · Circulation · doi:10.1161/01.cir.0000132482.95686.87 · Cited by 260
Digoxin. A neurohormonal modulator in heart failure?
Gheorghiade, M., & Ferguson, D. (1991) · Circulation · doi:10.1161/01.cir.84.5.2181 · Cited by 197
Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure
Krum, H., Bigger, T., Goldsmith, R. L., & Packer, M. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00417-o · Cited by 185
van Veldhuisen, D. J., Man in't Veld, A. J., Dunselman, P. H. J. M., Lok, D. J. A., Dohmen, H. J. M., Poortermans, J. C., Withagen, A. J. A. M., Pasteuning, W. H., Brouwer, J., & Lie, K. I. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90579-p · Cited by 163
Clinical benefits of low serum digoxin concentrations in heart failure
Adams, K. F., Gheorghiade, M., Uretsky, B. F., Patterson, J. H., Schwartz, T. A., & Young, J. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01708-4 · Cited by 160
Gheorghiade, M., Hall, V., Lakier, J. B., & Goldstein, S. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90561-5 · Cited by 147
Slatton, M. L., Irani, W. N., HALL, S. A., Marcoux, L., Page, R. L., Grayburn, P. A., & Eichhorn, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00057-0 · Cited by 133
Digitalis: new actions for an old drug
Wasserstrom, J. A., & Aistrup, G. L. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00707.2004 · Cited by 133
Fedida, D., Noble, D., RANKIN, A. C., et al. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016795 · Cited by 122
Gheorghiade, M., Hall, V. B., Jacobsen, G., Alam, M., Rosman, H., & Goldstein, S. (1995) · Circulation · doi:10.1161/01.cir.92.7.1801 · Cited by 121
Ahmed, A., Pitt, B., Rahimtoola, S. H., Waagstein, F., White, M., Love, T. E., & Braunwald, E. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.12.001 · Cited by 120
Gheorghiade, M., Patel, K., Filippatos, G. S., Anker, S. D., van Veldhuisen, D. J., Cleland, J. G. F., Metra, M., Aban, I., Greene, S. J., Adams, K. F., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft010 · Cited by 117
Digoxin reduces cardiac sympathetic activity in severe congestive heart failure
Newton, G. E., Tong, J., Schofield, A. M., Baines, A. D., Floras, J. S., & Parker, J. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00120-9 · Cited by 113
Cardiac Glycosides as Novel Inhibitors of Human Ether-a-go-go-Related Gene Channel Trafficking
Wang, L., Wible, B. A., Wan, X., & Ficker, E. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113043 · Cited by 93
Weitzen, S. H., Lapane, K. L., Toledano, A. Y., Hume, A. L., & Mor, V. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.986 · Cited by 93
Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure
Freeman, J. V., Yang, J., Sung, S. H., Hlatky, M. A., & Go, A. S. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.000079 · Cited by 79
Bourge, R. C., Fleg, J. L., Fonarow, G. C., Cleland, J. G. F., McMurray, J. J. V., van Veldhuisen, D. J., Gheorghiade, M., Patel, K., Aban, I., Allman, R. M., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.001 · Cited by 64
Brouwer, J., van Veldhuisen, D. J., Veld, A. J. M. I. '., Dunselman, P. H. J. M., Boomsma, F., Haaksma, J., & Lie, K. I. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00285-3 · Cited by 63
Georgiopoulou, V. V., Kalogeropoulos, A. P., Giamouzis, G., Agha, S. A., Rashad, M. A., Waheed, S., Laskar, S. R., Smith, A. L., & Butler, J. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.807032 · Cited by 60
End of the Oldest Controversy in Medicine — Are We Ready to Conclude the Debate on Digitalis?
Packer, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360809 · Cited by 56
Digoxin Use and Heart Failure Outcomes: Results from the Valsartan Heart Failure Trial (Val‐HeFT)
Butler, J., Anand, I. S., Kuskowski, M. A., Rector, T. S., Carson, P. E., Cohn, J. N., & for the Val‐HeFT Investigators (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00161.x · Cited by 50
The Effect of Gender on Outcome in Digitalis-Treated Heart Failure Patients
Domański, M., Fleg, J. L., Bristow, M. R., & Knox, S. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.07.002 · Cited by 47
Yusuf, S., & Negassa, A. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119770 · Cited by 37
Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial
Lee, A. Y., Kutyifa, V., Ruwald, M. H., McNitt, S. A., Polonsky, B., Zaręba, W., Moss, A. J., & Ruwald, A. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.016 · Cited by 37
Determination of vital status at the end of the DIG trial
Collins, J. O., Howell, C. L., Horney, R. A., & FORTHEDIGITALISINVESTIGATIONGR (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00135-1 · Cited by 36
Potential Effects of Digoxin on Long-Term Renal and Clinical Outcomes in Chronic Heart Failure
Testani, J. M., Brisco, M. A., Tang, W. H. W., Kimmel, S. E., OWENS, A. T., Forfia, P. R., & Coca, S. G. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.03.002 · Cited by 29
Digoxin treatment in heart failure — Unveiling risk by cluster analysis of DIG data
Ather, S., Peterson, L. E., Divakaran, V. G., Deswal, A. M., Ramasubbu, K., Giorgberidzė, I., Blaustein, A., Wehrens, X. H. T., Mann, D. L., & Bozkurt, B. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.04.021 · Cited by 29
Dhaliwal, A. S., Brėdikis, A. J., Habib, G. B., Carabello, B. A., Ramasubbu, K., & Bozkurt, B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.014 · Cited by 29
Eichhorn, E. J., Lukas, M. A., Wu, B., & Shusterman, N. H. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01146-2 · Cited by 28
Low-dose digoxin in patients with heart failure
van Veldhuisen, D. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01710-2 · Cited by 25
Cox, J. L., Ramer, S. A., Lee, D. S., Humphries, K. H., Pilote, L., Svenson, L., & Tu, J. V. (2005) · PubMed · Cited by 23
Cleland, J. G. F., & Cullington, D. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.859322 · Cited by 22
Brophy, J. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi686 · Cited by 21
ADELSTEIN, E. C., SCHWARTZMAN, D. S., Jain, S. K., Bazaz, R. R., & Saba, S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.007 · Cited by 15
EFFECT OF DIGOXIN ON PLASMA-RENIN-ACTIVITY IN MAN
Antonello, A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91231-9 · Cited by 15
Hopper, I., Skiba, M. A., von Lueder, T. G., Watanabe, M., Funston, R., Tonkin, A. M., & Krum, H. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.07.003 · Cited by 9
D’Agostino (1998) · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
Cited by
Cleland, J. G. F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J. S., Manzano, L., McMurray, J. J. V., Ruschitzka, F., van Veldhuisen, D. J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx564 · Cited by 659
Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation · doi:10.1161/circulationaha.106.628347 · Cited by 605
Titration of medical therapy for heart failure with reduced ejection fraction
Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., Duffy, C. I., Hill, C. L., McCague, K., Patterson, J. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.015 · Cited by 500
Devereaux, P. J., Beattie, W. S., Choi, P. T.-L., Badner, N. H., Guyatt, G. H., Villar, J. C., Cinà, C. S., Leslie, K., Jacka, M. J., Montori, V. M., et al. (2005) · BMJ · doi:10.1136/bmj.38503.623646.8f · Cited by 438
The vulnerable phase after hospitalization for heart failure
Greene, S. J., Fonarow, G. C., Vaduganathan, M., Khan, S. S., Butler, J., & Gheorghiade, M. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.14 · Cited by 406
Metadata
- Authors
- Konstantinou, D. M., Karvounis, H., & Giannakoulas, G.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 134
- Issue
- 3
- Pages
- 311-319
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2340731691
- Cited by
- 870
- References
- 79
- FWCI
- 45.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.